Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
D000661:Amphetamine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D002552:Cerebral Ventricles; D003891:Desipramine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004357:Drug Synergism; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D007267:Injections; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D009638:Norepinephrine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects; D013997:Time Factors
D006892:Hydroxydopamines; D008781:Methyltyrosines; D012110:Reserpine; D000661:Amphetamine; D003891:Desipramine; D003913:Dextroamphetamine; D009638:Norepinephrine